US Patent Issued to Foundation Medicine on Jan. 13 for "ALK and NTRK1 fusion molecules and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,873, issued on Jan. 13, was assigned to Foundation Medicine Inc. (Boston).

"ALK and NTRK1 fusion molecules and uses thereof" was invented by Maureen T. Cronin (Boston), Doron Lipson (Chestnut Hill, Mass.) and Roman Yelensky (Newton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel ALK and NTRK1 fusion molecules and uses are disclosed."

The patent was filed on July 15, 2021, under Application No. 17/377,231.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12522873&OS=12522...